Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Current Deferred Revenue (2020 - 2026)

Metlife's Current Deferred Revenue history spans 7 years, with the latest figure at $5.2 billion for Q1 2026.

  • Quarterly Current Deferred Revenue rose 9.51% to $5.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Mar 2026, up 9.51% year-over-year, with the annual reading at $5.2 billion for FY2025, 11.37% up from the prior year.
  • Current Deferred Revenue came in at $5.2 billion for Q1 2026, roughly flat from $5.2 billion in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $5.2 billion in Q1 2026 to a low of $3.8 billion in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $4.6 billion (2024), against an average of $4.5 billion.
  • Year-over-year, Current Deferred Revenue grew 17.22% in 2023 and then rose 2.16% in 2024.
  • Metlife's Current Deferred Revenue stood at $4.1 billion in 2022, then increased by 10.5% to $4.5 billion in 2023, then increased by 2.16% to $4.6 billion in 2024, then rose by 11.37% to $5.2 billion in 2025, then rose by 0.43% to $5.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Current Deferred Revenue are $5.2 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.1 billion (Q3 2025).